Health Tidings Mergers & AcquisitionsEli Lilly and UNICEF USA Strengthen Childhood NCD Care in LMICs Eli Lilly and UNICEF USA Strengthen Childhood NCD Care in LMICs Read Post »
Health Tidings Mergers & AcquisitionsEnodia Therapeutics Acquires Sec61-Based Assets from Kezar Life Sciences Enodia Therapeutics Acquires Sec61-Based Assets from Kezar Life Sciences Read Post »
Regulatory & Health PolicyFDA Seeks Public Input on Drug Repurposing Opportunities FDA Seeks Public Input on Drug Repurposing Opportunities Read Post »
Mergers & AcquisitionsBoehringer Ingelheim Licenses Preclinical Antibody from Immunitas for Infla... Boehringer Ingelheim Licenses Preclinical Antibody from Immunitas for Infla... Read Post »
Mergers & AcquisitionsRigel Acquires Global Rights to Arvinas and Pfizer’s VEPPANU Rigel Acquires Global Rights to Arvinas and Pfizer’s VEPPANU Read Post »
Health Tidings Mergers & AcquisitionsBMS and Hengrui Forge a $15.2 Billion Drug Discovery Alliance BMS and Hengrui Forge a $15.2 Billion Drug Discovery Alliance Read Post »
Health Tidings Mergers & AcquisitionsGSK Aligns With CTTQ to Expand Access to Bepirovirsen in China GSK Aligns With CTTQ to Expand Access to Bepirovirsen in China Read Post »
Health Tidings Mergers & AcquisitionsOncotelic-Lunai N2B Deal Gains Momentum Amid Rising Focus on CNS Drug Deliv... Oncotelic-Lunai N2B Deal Gains Momentum Amid Rising Focus on CNS Drug Deliv... Read Post »
Regulatory & Health PolicyFDA Lays the Groundwork for Better Pregnancy Drug Safety Evidence FDA Lays the Groundwork for Better Pregnancy Drug Safety Evidence Read Post »
Mergers & AcquisitionsRoche to Acquire PathAI in Up to $1.05 Billion Digital Pathology Deal Roche to Acquire PathAI in Up to $1.05 Billion Digital Pathology Deal Read Post »
Health Tidings Mergers & AcquisitionsGSK Partners With Halozyme to Develop Subcutaneous ADC Therapies GSK Partners With Halozyme to Develop Subcutaneous ADC Therapies Read Post »
Health Tidings Mergers & AcquisitionsGSK Licenses SiranBio’s siRNA Candidate SA030 in Up to $1 Billion Deal GSK Licenses SiranBio’s siRNA Candidate SA030 in Up to $1 Billion Deal Read Post »
Health Tidings Mergers & AcquisitionsBayer to Acquire Perfuse Therapeutics in Up to USD 2.45 Billion Ophthalmolo... Bayer to Acquire Perfuse Therapeutics in Up to USD 2.45 Billion Ophthalmolo... Read Post »
Health Tidings Mergers & AcquisitionsHalozyme Licenses Hypercon Technology to Oruka Therapeutics for ORKA-001 Halozyme Licenses Hypercon Technology to Oruka Therapeutics for ORKA-001 Read Post »
Health Tidings Mergers & AcquisitionsArrowhead Takes Aim at MASH Genetics with Madrigal Licensing Deal Arrowhead Takes Aim at MASH Genetics with Madrigal Licensing Deal Read Post »
Health Tidings Mergers & AcquisitionsEvotec–Almirall Hit Preclinical Milestone for Skin Disease Therapy Evotec–Almirall Hit Preclinical Milestone for Skin Disease Therapy Read Post »
Health Tidings Mergers & AcquisitionsBioCryst and Neopharmed Gentili Sign Navenibart Deal to Support 2027 Filing BioCryst and Neopharmed Gentili Sign Navenibart Deal to Support 2027 Filing Read Post »
Mergers & AcquisitionsUCB Acquires Candid Therapeutics in $2.2 Billion Autoimmune Deal UCB Acquires Candid Therapeutics in $2.2 Billion Autoimmune Deal Read Post »
Health Tidings Mergers & AcquisitionsUCB Taps IMIDomics to Power Its Precision Medicine Engine UCB Taps IMIDomics to Power Its Precision Medicine Engine Read Post »
Regulatory & Health PolicyFDA Acts to Restrict Compounding of Popular GLP-1 Therapies from Bulk Subst... FDA Acts to Restrict Compounding of Popular GLP-1 Therapies from Bulk Subst... Read Post »
Regulatory & Health PolicyNICE Recommends Rozanolixizumab as New Option for Uncontrolled gMG NICE Recommends Rozanolixizumab as New Option for Uncontrolled gMG Read Post »
Mergers & AcquisitionsChiesi Seals a Strategic Win with $1.9B KalVista Acquisition Chiesi Seals a Strategic Win with $1.9B KalVista Acquisition Read Post »
Food Health Tidings Regulatory & Health PolicyWhy FDA’s Infant Formula Findings Reassure, Yet Call for Vigilance Why FDA’s Infant Formula Findings Reassure, Yet Call for Vigilance Read Post »
Mergers & AcquisitionsTeva to Acquire Emalex and Add Tourette Drug Ecopipam Teva to Acquire Emalex and Add Tourette Drug Ecopipam Read Post »
Mergers & AcquisitionsProfluent and Eli Lilly Chase the ‘Holy Grail’ of DNA Editing Profluent and Eli Lilly Chase the ‘Holy Grail’ of DNA Editing Read Post »
Health Tidings Regulatory & Health PolicyMHRA and FDA Drive Changes to Improve Trial Efficiency MHRA and FDA Drive Changes to Improve Trial Efficiency Read Post »
Health Tidings Mergers & AcquisitionsBioMarin Bolsters Its Rare Disease Portfolio Through Amicus Acquisition BioMarin Bolsters Its Rare Disease Portfolio Through Amicus Acquisition Read Post »
Mergers & AcquisitionsEli Lilly Bets Big on Next-Gen JAK2 Science with Ajax Therapeutics Deal Eli Lilly Bets Big on Next-Gen JAK2 Science with Ajax Therapeutics Deal Read Post »
Health Tidings Mergers & AcquisitionsSun Pharma Acquires Organon in $11.75 Billion Deal Sun Pharma Acquires Organon in $11.75 Billion Deal Read Post »
Mergers & AcquisitionsSerum Institute Joins VaxThera to Expand Vaccine Access in Colombia Serum Institute Joins VaxThera to Expand Vaccine Access in Colombia Read Post »
Mergers & AcquisitionsSerum Institute of India Teams with Oxford to Reinforce the Fight Against M... Serum Institute of India Teams with Oxford to Reinforce the Fight Against M... Read Post »
Regulatory & Health PolicyWHO Prequalification Elevates Novartis’ Coartem Baby in Malaria Care for ... WHO Prequalification Elevates Novartis’ Coartem Baby in Malaria Care for ... Read Post »
Regulatory & Health PolicyFDA Accelerates the Clock on Psychedelic Research After Federal Order FDA Accelerates the Clock on Psychedelic Research After Federal Order Read Post »
Health Tidings Mergers & AcquisitionsAbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE AbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE Read Post »
Mergers & AcquisitionsApotex to Acquire Cumberland’s Branded Drug Portfolio in $100M Deal Apotex to Acquire Cumberland’s Branded Drug Portfolio in $100M Deal Read Post »
Health Tidings Mergers & AcquisitionsAmneal Bets Big on Biosimilars with Kashiv Acquisition Amneal Bets Big on Biosimilars with Kashiv Acquisition Read Post »
Mergers & AcquisitionsMerck Builds AI-Enabled Enterprise with Support from Google Cloud Merck Builds AI-Enabled Enterprise with Support from Google Cloud Read Post »
Regulatory & Health PolicyNICE Greenlights Zanidatamab for Previously Treated Biliary Tract Cancer NICE Greenlights Zanidatamab for Previously Treated Biliary Tract Cancer Read Post »
Health Tidings Mergers & AcquisitionsCompass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Compass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Read Post »
Health Tidings Mergers & AcquisitionsBiogen Takes Full Control of Felzartamab from TJ Biopharma Biogen Takes Full Control of Felzartamab from TJ Biopharma Read Post »
Health Tidings Mergers & AcquisitionsEli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Eli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Read Post »
Health Tidings Regulatory & Health PolicyFederal Order Expands Access and Research for Psychedelic Therapies Federal Order Expands Access and Research for Psychedelic Therapies Read Post »
Health Tidings Mergers & AcquisitionsUCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move UCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move Read Post »
Health Tidings Mergers & AcquisitionsGilead Sciences, Inc. Clears Final Hurdles, Locks in Arcellx, Inc. Deal Gilead Sciences, Inc. Clears Final Hurdles, Locks in Arcellx, Inc. Deal Read Post »
Health Tidings Mergers & AcquisitionsVir Biotechnology Closes Astellas Deal to Advance VIR-5500 in Prostate Canc... Vir Biotechnology Closes Astellas Deal to Advance VIR-5500 in Prostate Canc... Read Post »
Mergers & AcquisitionsAligos and Amoytop Enter Strategic Licensing Pact for HBV Therapy in Greate... Aligos and Amoytop Enter Strategic Licensing Pact for HBV Therapy in Greate... Read Post »
Regulatory & Health PolicyFDA Lays the Groundwork for Expanding Testosterone Therapy’s Reach FDA Lays the Groundwork for Expanding Testosterone Therapy’s Reach Read Post »
Mergers & AcquisitionsMeiraGTx Takes the Lead on Bota-vec, Driving Toward Regulatory Approval in ... MeiraGTx Takes the Lead on Bota-vec, Driving Toward Regulatory Approval in ... Read Post »
Regulatory & Health PolicySandoz Plants a Strategic Supply Anchor in Africa with Rwanda Manufacturing... Sandoz Plants a Strategic Supply Anchor in Africa with Rwanda Manufacturing... Read Post »
Health Tidings Mergers & AcquisitionsIllumina and D3b Construct a Unified Genomic Core to Break Pediatric Data S... Illumina and D3b Construct a Unified Genomic Core to Break Pediatric Data S... Read Post »
